Stephen Raymond Self Insider Profile
4 Followers
Stephen Raymond Self, former Development Director at E Therapeutics, holds 273.58K shares in E Therapeutics (Ticker: GB:ETX). Most recently, Stephen Raymond Self Bought 20,000 shares of E Therapeutics on Feb 14, 2013 for an estimated value of 6.50K .
Stephen Raymond Self's Trading History
| ETXE Therapeutics | Feb 14, 2013 | ― | Informative Buy | 6.50K | £24.62K | |||||||||||||||||||||||||||||||||||||||||||
GB:ETX
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Stephen Raymond Self insider profile FAQ
What is the percentage of profitable transactions made by Stephen Raymond Self?
The percentage of profitable transactions made by Stephen Raymond Self is 38%.
What is the average return per transaction made by Stephen Raymond Self?
The average return per transaction made by Stephen Raymond Self is -12.80%.
What stocks does Stephen Raymond Self hold?
Stephen Raymond Self holds: GB:ETX stocks.
What was Stephen Raymond Self’s latest transaction?
Stephen Raymond Self’s latest transaction was an Informative Buy of 6.50K .
What is Stephen Raymond Self's role in E Therapeutics?
Stephen Raymond Self's role in E Therapeutics is Development Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
